Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Cumberland Pharmaceuticals, In - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
CPIX
Nasdaq
2834
https://www.cumberlandpharma.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Cumberland Pharmaceuticals, In
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q4 2023 Earnings Call Transcript
- Mar 7th, 2024 4:52 pm
Cumberland Pharmaceuticals Full Year 2023 Earnings: US$0.44 loss per share (vs US$0.38 loss in FY 2022)
- Mar 7th, 2024 10:20 am
Q4 2023 Cumberland Pharmaceuticals Inc Earnings Call
- Mar 6th, 2024 11:55 am
Cumberland Pharmaceuticals Reports Annual 2023 Financial Results
- Mar 5th, 2024 9:05 pm
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2023 FINANCIAL RESULTS
- Feb 27th, 2024 9:05 pm
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q3 2023 Earnings Call Transcript
- Nov 12th, 2023 1:48 pm
Cumberland Pharmaceuticals Reports Third Quarter 2023 Financial Results
- Nov 7th, 2023 9:05 pm
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS
- Oct 31st, 2023 8:05 pm
NEW VIBATVĀ® PEDIATRIC PUBLICATION HIGHLIGHTS ITS SAFETY IN PATIENTS 2 TO 17 YEARS OF AGE
- Oct 10th, 2023 8:05 pm
Cumberland Pharmaceuticals Reports Revenue and Earnings Growth Second Quarter 2023
- Aug 8th, 2023 8:05 pm
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS
- Aug 1st, 2023 8:05 pm
NEW PUBLICATION SUPPORTS THE USE OF CALDOLORĀ® IN NEWBORN PEDIATRIC PATIENTS
- Jun 26th, 2023 1:00 pm
CPIX: A Solid Stock with an Exciting Catalyst
- May 31st, 2023 9:22 am
CUMBERLAND PHARMACEUTICALS ANNOUNCES FDA CLEARANCE OF IND FOR NEW TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS
- May 23rd, 2023 1:00 pm
CALDOLORĀ® NOW FDA APPROVED FOR TREATMENT OF FEVER & PAIN IN INFANTS
- May 15th, 2023 1:00 pm
Cumberland Pharmaceuticals Reports First Quarter 2023 Financial Results & Company Update
- May 9th, 2023 8:05 pm
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS
- May 2nd, 2023 8:05 pm
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Screens Well But There Might Be A Catch
- Apr 17th, 2023 1:52 pm
Scroll